Anti-GRM2 VHH (DN10) (TAB-0002CL-VHH)
The anti-metabotropic glutamate receptor subtype 2 (mGluR2) conformational single domain antibody target mGluR2 which contribute to the fine-tuning of synaptic efficacy. The llama-derived anti-mGluR2 single domain antibody act as a positive allosteric modulator and are able to stabilized the active state of mGluR2. Therefore, the anti-mGluR2 single domain antibody can be useful in the treatment of schizophrenia, epilepsy, addiction/drug dependence, Parkinson's disease, pain, sleep disorders and Huntington's disease.
- Llama antibody
- Rat, human
- Related Disease
- Schizophrenia, epilepsy, addiction/drug dependence, Parkinson's disease, pain, sleep disorders, Huntington's disease
- Alternative Names
- GRM2, GLUR2, GPRC1B, MGLUR2, mGlu2, glutamate metabotropic receptor 2
- Entrez Gene ID
- UniProt ID
For lab research use only, not for diagnostic, therapeutic or any in vivo human use.
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us